Zhaoke Ophthalmology
Zhaoke Ophthalmology, also known as Zhaoke, is a prominent player in the ophthalmic industry, headquartered in China. Founded in 2016, the company has rapidly established itself as a leader in the development and commercialisation of innovative ophthalmic therapies and surgical solutions. With a strong operational presence across major regions in Asia, Zhaoke focuses on addressing critical eye health challenges through its advanced product offerings. The company’s core services include the development of cutting-edge treatments for various eye conditions, particularly in the fields of glaucoma and retinal diseases. Zhaoke's commitment to research and development has led to significant milestones, positioning it as a trusted name in ophthalmology. With a robust pipeline of products and a dedication to improving patient outcomes, Zhaoke Ophthalmology continues to make strides in the global healthcare landscape.
DitchCarbon Score
How does Zhaoke Ophthalmology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhaoke Ophthalmology's score of 10 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zhaoke Ophthalmology's reported carbon emissions
In 2023, Zhaoke Ophthalmology reported total carbon emissions of approximately 2,937,900 kg CO2e. This figure includes 0 kg CO2e from Scope 1 emissions, 2,764,500 kg CO2e from Scope 2 emissions, and 173,400 kg CO2e from Scope 3 emissions. Comparatively, in 2022, the company had total emissions of about 2,929,700 kg CO2e, with Scope 2 emissions accounting for 2,868,200 kg CO2e and Scope 3 emissions at 61,500 kg CO2e. The increase in emissions from 2022 to 2023 indicates a slight upward trend, particularly in Scope 2 emissions. Zhaoke Ophthalmology has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or targets suggests that the company may still be in the early stages of formalising its climate commitments. Overall, Zhaoke Ophthalmology's emissions data highlights the need for enhanced climate strategies to address their carbon footprint effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 37,000 | 00,000 | - | - |
| Scope 2 | 1,627,800 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 16,500 | 00,000 | 00,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zhaoke Ophthalmology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
